Clinical Trial

Olive Oil Supplementation for Heart Failure With Reduced Ejection Fraction

Study acronym: OLEA-HF
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The OLEA-HF study aims to explore whether daily supplementation of extra-virgin olive oil (EVOO) for 12 weeks during participation in a cardiac rehabilitation program (standard of care) is feasible in patients with heart failure with reduced ejection fraction (HFrEF). The investigators will also determine the effects of EVOO on functional capacity and quality of life.
Trial Details
NCT Number NCT07644806
Lead Sponsor Old Dominion University
Conditions Heart Failure With Reduced Ejection Fraction (HFrEF)
Enrollment 40 participants
Start Date 2026-07-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-12